Suven Pharmaceuticals : Analysts/Institutional Investor Meet/Con. Call Updates

CSD/BSE&NSE/CC/2022-23

December 26, 2022

To	To
The Manager	The Manager
Department of Corporate Services	Listing Department
BSE Limited	National Stock Exchange of India Limited
25th Floor, P. J. Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai - 400 001	Bandra (E), Mumbai - 400 051
Scrip Code: 543064	Scrip Symbol: SUVENPHAR
Dear Sir/Madam,

Sub: Schedule of Conference Call for Investors

With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on today i.e. Monday, December 26, 2022 at 2:30 PM IST to discuss today's announcement that Advent International is to acquire a significant stake in Suven Pharmaceuticals from the Jasti Family.

This is for your information and record.

Thanking You,

Yours faithfully,

For Suven Pharmaceuticals Limited

	Digitally signed by:
HANUMANTHANUMANTHA RAO
HA RAO	KOKKONDA
DN: CN = HANUMANTHA RAO
KOKKONDA email =
	[e-mail] C
KOKKONDADate: 2022.12.26 10:24:23 +05'30'
	= IN O = Personal
K Hanumantha Rao
Company Secretary

Encl: as above

Suven Pharmaceuticals Limited

Registered Office: # 8-2-334 I SDE Serene Chambers I 3rd Floor I Road No.5

Avenue 7 I Banjara Hills I Hyderabad - 500034 I Telangana I India I CIN: L24299TG2018PLC128171

Tel: [phone] I Fax: [phone] I Email: [e-mail] I www.suvenpharm.com

Suven Pharmaceuticals Ltd to host Conference call Today,

December 26, 2022 @ 2.30 pm IST

Suven Pharmaceuticals Ltd will be conducting a conference call to discuss today's announcement that Advent International is to acquire a significant stake in Suven Pharmaceuticals from the Jasti family. Suven Pharmaceuticals Ltd will be represented by members of the senior management team.

The conference call will be initiated with a brief discussion after which the floor will be opened for Q&As.

In order to pre-register: Copy this URL in your browser:

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=8824171&linkSecur

ityString=2accd4e320

Details of the conference call are as follows:

	Timing	2:30 pm IST on Monday, December 26, 2022
	Conference dial-in
	Primary number	[phone]/[phone]
	Singapore Toll Free Number	800 101 2045
	Hong Kong Toll Free Number	800 964 448
	USA Toll Free Number	1 866 746 2133
	UK Toll Free Number	0 808 101 1573
- ENDS -

For further information please contact

Venkatraman Sunder, (VP - Corporate Afffairs)	Gavin Desa / Rishab Barar
Suven Pharmaceuticals Limited	CDR India
Tel: [phone]	Tel: [phone]/1235
Email:[e-mail]	Email:[e-mail]
	[e-mail]